PCM
GMED icon

Penserra Capital Management’s Globus Medical GMED Stock Holding History

Penserra Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,515
Closed -$373K – 1095
2024
Q4 		$373K Buy
+4,515
New +$356K 0.01% 614
2024
Q3 		– Sell
-4,067
Closed -$279K – 1193
2024
Q2 		$279K Buy
+4,067
New +$243K ﹤0.01% 678
2018
Q4 		– Sell
-2,850
Closed -$161K – 689
2018
Q3 		$161K Buy
+2,850
New +$150K 0.01% 413
2016
Q1 		– Sell
-11,084
Closed -$308K – 1002
2015
Q4 		$308K Buy
+11,084
New +$278K 0.03% 139

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penserra Capital Management's GMED Position: Q1 2025 in Review

Penserra Capital Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 4,515 shares — an estimated $373K sold.

Penserra Capital Management first reported a position in GMED in Q4 2015 and held it in 4 quarters. The position peaked at $373K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Penserra Capital Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Penserra Capital Management sold 4,515 Globus Medical shares in Q1 2025, an estimated $373K.
  • Penserra Capital Management first reported a position in Globus Medical in Q4 2015 and held it in 4 quarters.
  • Penserra Capital Management's Globus Medical position peaked at $373K in Q4 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Penserra Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.